Quality Assurance
Discover how we deliver and maintain the excellence of our assay development and bioanalytical solutions
Quality Science delivered on time and
within budget
Synexa’s network of global labs across the UK, Finland and South Africa are underpinned by robust quality management procedures, ensuring quality, reliability and consistency at every stage of your study.
Strict adherence to GCLP/GLP/GMP and FDA/EMA guidelines.
Delivering Quality Science with Integrity and Compliance
Â
All studies are conducted within our GCLP Compliant laboratories (Good Clinical Laboratory Practice (GCLP) standard, 2011, ISBN 978-1-904610-00-7.) and in line with our policies and standard operating procedures. Synexa also incorporates the requirements of GCP (ICH E6), including the referenced requirements of GLP (OECD). Validations are performed according to the requirements of the applicable FDA guidance for industry and EMA guidelines. Synexa is committed to providing quality science that is reputable, trustworthy, and clinically relevant to our clients.
Global Operational Support
Â
Our Global Operations team is key to supporting our global customers and delivering reliable and trusted clinical laboratory solutions. We are focused on excellence, ensuring high-quality scientific customer service delivery, relying on extensive experience and scientific judgment to plan and accomplish all deliverables.
Project Management
Â
Our team of project managers are qualified scientists with laboratory experience, excellent organisational and communication skills and are responsible for the complex task of delivering studies on time and within budget. Each project manager maintains frequent, high-quality communication between our customers, CROs and scientific teams, mitigating delays by finding timely solutions. Our team has vast experience managing global studies and are committed to achieving the desired outcomes of every study.
Improving the quality of human health
Contact us
Discuss biomarker and bioanalytical solutions to accelerate your therapeutic pipeline